|
Status |
Public on May 03, 2021 |
Title |
Intratumoral TFR cells curtail anti-PD-1 treatment efficacy [human] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Follicular regulatory T cells (TFR cells) and their functional role in cancer have been completely disregarded so far. Our data identify that as a critical oversight, as these cells account for a substantial proportion of tumor-infiltrating CD4+ T cells
|
|
|
Overall design |
Assessment of the transcriptomic profile of tumor-infiltrating TREG and TFR cells
|
Web link |
https://doi.org/10.2139/ssrn.3596586
|
|
|
Contributor(s) |
Eschweiler S, Clarke J, Ramirez Suastegui C, Panwar B, Madrigal A, Chee SJ, Woo E, Alzetani A, Friedmann P, Sanchez-Elsner T, Ay F, Ottensmeier C, Vijayanand P |
Citation(s) |
34168370 |
Submission date |
Jun 06, 2019 |
Last update date |
Aug 02, 2021 |
Contact name |
Pandurangan Vijayanand |
E-mail(s) |
vijay@lji.org
|
Organization name |
La Jolla Institute for Allergy and Immunology
|
Department |
Division of Vaccine Discovery
|
Lab |
VD-Vijay
|
Street address |
9420 Athena Circle
|
City |
La Jolla |
State/province |
California |
ZIP/Postal code |
92037 |
Country |
USA |
|
|
Platforms (2) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (20)
|
|
This SubSeries is part of SuperSeries: |
GSE132297 |
Intratumoral TFR cells curtail anti-PD-1 treatment efficacy |
|
Relations |
BioProject |
PRJNA547554 |
SRA |
SRP200649 |